Baird analyst Whit Mayo raised his price target on Universal Health to $140 from $122 following good Q4 results. The analyst said the results were underpinned by incredibly strong acute growth and improved health plan trends. He noted improved guidance and a clear inflection with the behavioral health side. Mayo reiterated his Outperform rating on Universal Health shares.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here